We're thrilled to be recognized as a Leading Seasoned Vendor in AIM Research’s - PeMa Quadrant Pharma Commercial Analytics Platform 2025! This is a testament to our technical maturity, deep domain expertise, and impact in the market. As the AI-driven analytics industry evolves, investing in domain-specific #AI isn’t just an advantage—it’s necessary, and we have the advantage of starting on this mission 7 years ago. Since then, we have successfully enabled efficient, data-driven decision-making, improving field operations and optimizing overall market performance one client at a time. A huge thank you to AIM Research for this recognition and for shedding light on the evolving landscape of pharma #commercialanalytics platforms. #PharmaAnalytics #AIinPharma #GenAI #FutureOfPharma #DataDriven #LifeScience #PeMaQudrant
Pharma analytics is evolving fast, and AI-driven, patient-centric insights are now a must-have. Vendors that don’t invest in domain-specific AI risk being left behind. Our latest report explores how the pharma commercial analytics industry has evolved over the past year, highlighting the top vendors driving innovation. It covers key market trends, challenges, and the PeMa Quadrant analysis, studying 18 leading vendors based on Market Penetration and Technical Maturity. Want to stay ahead? Download the full report now! ?? https://lnkd.in/d_8rD-6N ACTO | Axtria - Ingenious Insights | C5i | DataZymes | Hyntelo | IntegriChain | IQVIA | ODAIA | OKRA.ai | P360 | Tellius | Think360.ai | Trueblue | Veeva Systems | Verix | WhizAI | Within3 | ZS #PharmaAnalytics #AIinPharma #GenAI #FutureOfPharma #DataDriven #CommercialAnalytics, #AugmentedAnalytics #LifeScience #Pharmaceutical #PeMaQudrant